Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
193.46 USD | -1.27% |
|
-2.82% | -7.75% |
01-30 | Icon Portfolio of Ai Tools Drives Clinical Trial Efficiencies | CI |
01-17 | ICON Public Limited Company - Special Call |
Capitalization | 15.97B 15.44B 14.52B 12.88B 22.87B 1,401B 25.5B 175B 64.88B 575B 59.88B 58.67B 2,415B | P/E ratio 2024 * |
22.2x | P/E ratio 2025 * | 18.6x |
---|---|---|---|---|---|
Enterprise value | 18.62B 18B 16.93B 15.01B 26.66B 1,633B 29.73B 204B 75.63B 670B 69.8B 68.39B 2,815B | EV / Sales 2024 * |
2.25x | EV / Sales 2025 * | 2.09x |
Free-Float |
99.29% | Yield 2024 * |
-
| Yield 2025 * | - |
Last Transcript: ICON Public Limited Company
1 day | -1.27% | ||
1 week | -2.82% | ||
Current month | -2.82% | ||
1 month | -13.08% | ||
3 months | -10.02% | ||
6 months | -36.90% | ||
Current year | -7.75% |







Director | Title | Age | Since |
---|---|---|---|
Stephen Cutler
CEO | Chief Executive Officer | 64 | 2017-02-28 |
Director of Finance/CFO | 52 | 2024-09-30 | |
Gregory Licholai
CTO | Chief Tech/Sci/R&D Officer | 60 | 2021-10-31 |
Manager | Title | Age | Since |
---|---|---|---|
John Climax
CHM | Chairman | 72 | 2002-10-31 |
Ciaran Murray
CHM | Chairman | 62 | 2017-02-28 |
Stephen Cutler
BRD | Director/Board Member | 64 | 2015-11-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.68% | 0 M€ | -.--% | - | |
1.28% | 0 M€ | -.--% | - | |
0.91% | 4 M€ | +8.48% |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
-1.27% | -2.82% | -28.10% | -27.88% | 15.97B | ||
-1.50% | +3.75% | +38.33% | -3.02% | 47.96B | ||
-0.87% | +3.37% | -2.89% | -15.36% | 36.65B | ||
-0.77% | -0.06% | +5.35% | +24.92% | 26.22B | ||
-1.71% | -0.99% | +64.98% | +74.02% | 15.52B | ||
-3.01% | -17.30% | -67.17% | -79.66% | 12.55B | ||
-2.93% | -1.01% | +9.72% | -29.43% | 11.51B | ||
-1.90% | +1.42% | +14.68% | +106.42% | 10.98B | ||
+6.11% | +20.16% | - | - | 10.86B | ||
-2.59% | -7.39% | -7.65% | -22.06% | 8.93B | ||
Average | -1.36% | +0.26% | +3.03% | +3.11% | 19.72B | |
Weighted average by Cap. | -1.26% | +1.31% | +9.63% | +1.52% |
2024 * | 2025 * | |
---|---|---|
Net sales | 8.28B 8.01B 7.53B 6.68B 11.86B 726B 13.22B 90.54B 33.64B 298B 31.05B 30.42B 1,252B | 8.42B 8.14B 7.66B 6.79B 12.06B 738B 13.44B 92.06B 34.21B 303B 31.57B 30.93B 1,273B |
Net income | 730M 706M 664M 589M 1.05B 64.03B 1.17B 7.98B 2.97B 26.27B 2.74B 2.68B 110B | 886M 856M 805M 714M 1.27B 77.67B 1.41B 9.68B 3.6B 31.87B 3.32B 3.25B 134B |
Net Debt | 2.65B 2.56B 2.41B 2.13B 3.79B 232B 4.22B 28.93B 10.75B 95.2B 9.92B 9.72B 400B | 1.66B 1.6B 1.5B 1.33B 2.37B 145B 2.64B 18.09B 6.72B 59.54B 6.2B 6.08B 250B |
Date | Price | Change | Volume |
---|---|---|---|
25-02-07 | 193.46 $ | -1.27% | 404,601 |
25-02-06 | 195.94 $ | -0.24% | 543,222 |
25-02-05 | 196.41 $ | +1.62% | 490,303 |
25-02-04 | 193.27 $ | -1.15% | 766,171 |
25-02-03 | 195.51 $ | -1.79% | 655,307 |
Delayed Quote Nasdaq, February 07, 2025 at 04:00 pm
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ICLR Stock

MarketScreener is also available in this country: United States.
Switch edition